Fight Arthritis! Resources To Help You Fight Rheumatoid Arthritis

Free Arthritis Booklet | Fight Arthritis Shop | Arthritis Symptoms

Insurer Ordered to Pay $40000 for 'Off-Label' Use of Biologic Drug ... - Biologic Drug Report

February 19, 2007


Insurer Ordered to Pay $40000 for 'Off-Label' Use of Biologic Drug ...
Biologic Drug Report, FL - 1 hour ago
Drugs like Rituxan, which the FDA has approved to treat non-Hodgkin's lymphoma and rheumatoid arthritis, are among the priciest on the market. ...

Breakthrough for Can-Fite: CF102 Found to be Active Against ... - Business Wire (press release)

February 19, 2007


Breakthrough for Can-Fite: CF102 Found to be Active Against ...
Business Wire (press release), CA - 3 hours ago
This phase II trial in patients with Dry Eye Syndrome is added to the Company's ongoing clinical trial in patients with Rheumatoid Arthritis. ...
Can-Fite cancer drug effective against hepatitis Globes
all 3 news articles

2 new treatments for Crohn's due soon - Boston Globe

February 19, 2007



Boston Globe
2 new treatments for Crohn's due soon
Boston Globe, MA - 1 hour ago
Within days, Illinois-based Abbott Laboratories expects to win federal approval to sell its drug, Humira , currently used to treat rheumatoid arthritis, ...

HEALTH CALENDAR - Kansas.com

February 19, 2007


HEALTH CALENDAR
Kansas.com, KS - 17 minutes ago
... rheumatoid arthritis, irritable bowel syndrome, herpes vaccine, depression, herpes treatment, chronic constipation, headaches, adolescent HPV vaccine, ...

New Wound Healing & Hyperbaric Medicine Center opens at Highland - LubbockOnline.com

February 19, 2007


New Wound Healing & Hyperbaric Medicine Center opens at Highland
LubbockOnline.com, TX - 12 minutes ago
For some individuals, however, certain conditions derail the healing process and it becomes a complex medical problem requiring specialized treatment and ...

The Immune Response Corporation's Interim Phase II Data Suggest ... - Drug Newswire (press release)

February 19, 2007


The Immune Response Corporation's Interim Phase II Data Suggest ...
Drug Newswire (press release), CT - 20 minutes ago
The concept of an immune based treatment for HIV, pioneered by REMUNE(R), has attracted the interest of researchers, physicians, and patients around the ...